|25th October 2019||Raymond F Schinazi||7,906||Open or private purchase||$1.15||$9,091.90|
|24th October 2019||Raymond F Schinazi||5,094||Open or private purchase||$1.15||$5,858.10|
|23rd October 2019||Raymond F Schinazi||3,935||Open or private purchase||$1.04||$4,086.89|
|1st April 2019||Raymond F Schinazi||36,946||Conversion of derivative||$13.60||$502,465.60|
|1st April 2019||Raymond F Schinazi||56,102||Conversion of derivative||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
Cocrystal Pharma, Inc. is a biotechnology company. It focuses on the discovery and development of novel antiviral therapeutics. The company was founded on January 2, 2014 and is headquartered in Bothell, WA.